Small-scale water systems—those serving fewer than 10,000 people—supply drinking water to millions of households across rural and suburban areas. Yet these same systems face disproportionate hurdles when it comes to testing for emerging contaminants. Unlike large municipal utilities, small systems often operate with limited budgets, aging infrastructure, and fewer trained personnel. As a result, the detection and management of contaminants such as PFAS, pharmaceuticals, and microplastics remain a persistent and growing challenge. Addressing this gap is essential to protecting public health and ensuring water equity.

What Are Emerging Contaminants?

Emerging contaminants are chemicals or microorganisms that are not yet routinely monitored in drinking water but have been increasingly detected in the environment. They include a wide range of substances: pharmaceuticals, hormones, personal care products, industrial chemicals, pesticides, and nanomaterials. Many of these compounds are not removed effectively by conventional water treatment processes, raising concerns about long-term human health impacts such as endocrine disruption, developmental effects, and cancer.

The term “emerging” reflects shifting scientific understanding and improved analytical capabilities. As detection methods become more sensitive, previously undetectable trace levels come into focus. This evolving picture places small water systems in a difficult position: they must adapt to new knowledge without the financial or technical bandwidth of large utilities.

The Unique Challenges for Small-Scale Water Systems

Limited Financial and Technical Resources

Small water systems often operate with annual budgets that are orders of magnitude smaller than their urban counterparts. Testing for emerging contaminants requires capital investment in advanced instrumentation such as liquid chromatography-tandem mass spectrometry (LC-MS/MS) or high-resolution mass spectrometry. These instruments cost hundreds of thousands of dollars and demand specialized training to operate and maintain. Many small utilities cannot justify such expenditure for what may be infrequent sampling needs.

Even when testing is outsourced to commercial laboratories, the cost per sample for emerging contaminants can be prohibitively high—ranging from $200 to $1,000 per analyte per sample. With limited funds, small systems must prioritize basic compliance monitoring over proactive screening for unregulated contaminants. This leaves a critical blind spot in drinking water safety.

Sensitivity Requirements for Detection

Emerging contaminants are typically present in water at concentrations in the parts-per-trillion (ng/L) range. Detecting such low levels demands not only expensive instrumentation but also rigorous quality control and sample preparation. Common challenges include matrix effects (interference from other water constituents), contamination during sampling, and the need for isotopically labeled internal standards—which are costly and have limited commercial availability.

Field-deployable sensors and test kits are under development but remain in early stages for most emerging contaminants. For example, while immunoassay-based tests exist for some PFAS compounds, they often lack the sensitivity and specificity needed for regulatory compliance. Until inexpensive, robust field methods mature, small systems are heavily dependent on central laboratories that may be geographically distant, increasing turnaround times and sample degradation risks.

Regulatory and Compliance Gaps

Most emerging contaminants are not subject to federal Maximum Contaminant Levels (MCLs) under the Safe Drinking Water Act. For instance, the US Environmental Protection Agency (EPA) has not yet established enforceable limits for PFAS, though health advisories exist. Without regulatory drivers, small systems have little incentive to allocate scarce resources toward monitoring these compounds. State-level regulations vary widely, creating a patchwork of protection that leaves many communities vulnerable.

Furthermore, the lengthy process of establishing new MCLs (often taking years or decades) contrasts with the rapid pace at which new contaminants are identified. Small systems, already burdened by compliance with existing rules, may find it especially challenging to stay ahead of emerging threats without clear guidance and funding support.

Sample Collection and Preservation Issues

Proper sample collection for emerging contaminants involves strict protocols to avoid cross-contamination. Many substances are ubiquitous in consumer products and laboratory environments. For example, PFAS are present in many brands of plastic sampling bottles, deionized water systems, and even the clothing of field personnel. Small systems may lack training on these specialized procedures, leading to false positives or invalid results.

Sample preservation is equally critical. Some pharmaceuticals degrade quickly unless samples are acidified or stored at low temperatures. Field staff in small systems often work alone or with minimal backup, and the logistics of shipping temperature-sensitive samples to a distant lab within holding time limits can be a formidable barrier.

Lack of Baseline Data and Monitoring

Most small water systems have no historical data on emerging contaminants. This absence of baseline information makes it difficult to identify trends, assess source water vulnerability, or respond to contamination events. Without regular monitoring, a spill or chronic release may go undetected until health effects emerge.

Community water systems that rely on groundwater wells face particular challenges: groundwater contamination by PFAS or pharmaceuticals is often diffuse, and multiple sampling rounds are needed to characterize plumes. The financial burden of such long-term monitoring is often insurmountable for a village utility serving a few hundred homes.

The Most Concerning Emerging Contaminants in Small Systems

Per- and Polyfluoroalkyl Substances (PFAS)

PFAS are a large group of man-made chemicals used in non-stick coatings, firefighting foams, and water-repellent fabrics. They are extremely persistent in the environment and accumulate in the human body. A growing body of research links PFAS exposure to kidney cancer, thyroid disease, and immune system effects. The EPA’s PFAS Strategic Roadmap calls for stronger regulatory action, but small systems are often the ones most affected because they serve farming communities near airfields or military bases where PFAS-containing foams were used.

Testing for PFAS requires EPA Method 533 or 537.1, which can cost $300–$500 per sample. For a small system with 10 wells, an annual monitoring program could easily exceed the total annual water quality budget. Activated carbon or ion exchange treatment for PFAS removal adds millions in capital costs, far beyond the means of many small utilities.

Pharmaceuticals and Personal Care Products

Trace amounts of antibiotics, hormones, pain relievers, and fragrances are regularly found in source waters downstream from wastewater treatment plants. While individual concentrations are low, the cumulative effect of long-term exposure is not well understood. Antibiotics in water raise concerns about promoting antimicrobial resistance.

Small systems that draw from surface water or shallow groundwater near septic fields are particularly vulnerable. Monitoring requires advanced mass spectrometry, and no federal standards currently exist. The World Health Organization has noted that pharmaceuticals in drinking water are not an immediate risk at current levels, but advises precautionary monitoring—an expensive proposition for small systems.

Microplastics and Nanoplastics

Microplastics—particles smaller than 5 mm—have been found in tap water worldwide. While health effects remain under investigation, these particles can carry toxic chemicals and pathogens into the body. No standardized testing method exists for microplastics in drinking water, and analyses often require FTIR microscopy or Raman spectroscopy.

Small systems rarely have access to such equipment or expertise. The National Institute of Standards and Technology (NIST) is developing reference materials and methods, but widespread implementation in small facilities remains years away.

Pesticides and Industrial Chemicals

Agricultural runoff introduces a rotating cast of pesticides, herbicides, and fungicides into source waters. Some are legacy compounds like atrazine, while others are newer formulations not yet included in routine monitoring panels. Industrial chemicals such as 1,4-dioxane (a solvent stabilizer) are increasingly detected but difficult to treat.

Small systems in agricultural regions may face seasonal spikes in contamination that require targeted monitoring. However, without real-time sensors or frequent grab sampling, these spikes are often missed.

Strategies and Solutions

Development of Field-Deployable Testing Kits

Significant research is underway to create portable, low-cost sensors for emerging contaminants. For example, biosensors that use antibodies or aptamers can detect PFAS in minutes rather than days. Advances in paper-based microfluidics and smartphone-integrated detection may soon enable onsite testing for a fraction of the lab cost. While these technologies are not yet ready for regulatory compliance, they can serve as screening tools to prioritize samples for confirmatory analysis.

Public-private partnerships and university innovation hubs are critical to accelerating commercialization. Funding from the Bureau of Reclamation’s WaterSMART program and similar initiatives can help bring prototypes to small-system operators.

Leveraging Advanced Analytical Services

Small systems do not need to own sophisticated instruments. Regional water quality coalitions, state laboratories, and academic centers can offer centralized testing services. For example, a group of 20 small utilities could pool resources to contract with a commercial lab for quarterly PFAS monitoring at negotiated rates. Several states, including Michigan and Minnesota, have created free or subsidized PFAS testing programs for public water systems. Expanding such programs nationwide is a practical step.

Another approach is to use passive sampling devices—such as solid-phase microextraction (SPME) fibers—that can be deployed in source water for weeks at a time and then sent to a lab for analysis. This reduces the number of laboratory runs and provides integrated concentration data.

Enhanced Collaboration and Data Sharing

No single small system can tackle the emerging contaminant problem alone. Collaboration between water utilities, public health departments, researchers, and environmental agencies creates efficiencies. Shared databases—such as the Water Quality Data Portal—allow utilities to view contamination patterns in their region and plan accordingly. Regional workshops and webinars help disseminate best practices for sampling, treatment, and communication.

Federally funded technical assistance programs, such as those offered by the EPA’s Office of Ground Water and Drinking Water, provide free or low-cost consultations to small systems. These services can include training on emerging contaminants, grant writing, and treatment option assessments.

Policy Interventions and Funding Opportunities

Regulatory certainty is needed to drive investment. The EPA’s proposed PFAS MCL (4 ppt for PFOA and PFOS) will require all public water systems—including small ones—to monitor and treat if levels exceed the threshold. While this mandate is welcome, it must be accompanied by significant financial support. The bipartisan Infrastructure Investment and Jobs Act allocated $10 billion for PFAS and emerging contaminant remediation, but distribution to the smallest systems must be streamlined.

States can also adopt testing reimbursement programs, offer low-interest loans for equipment, and provide technical assistance grants. Additionally, the USDA Rural Development offers water and waste disposal loan and grant programs for rural communities; these should be expanded to specifically address emerging contaminants.

Community Engagement and Education

Residents served by small water systems are often overlooked in national conversations about water quality. Transparent communication about what is being tested—and why—builds trust and can spur local advocacy for funding. Simple fact sheets, town hall meetings, and water quality reports tailored to lay audiences help demystify complex issues.

Community science projects, where trained volunteers collect samples for university analysis, have successfully mapped PFAS contamination in several regions. Such initiatives not only generate valuable data but also empower residents to become stewards of their water resources.

Conclusion: A Path Forward

The challenges of testing for emerging contaminants in small-scale water systems are formidable but not insurmountable. A combination of technological innovation, collaborative resource sharing, policy support, and community engagement can close the gap. Every resident deserves access to safe drinking water, regardless of the size of their utility. By investing in solutions now—rather than waiting for a contamination crisis—we can protect both public health and the long-term sustainability of our most vital resource.